Mindfulness-based Cognitive Therapy for the Chronic Pain-early Cognitive Decline Co-morbidity Among Older Black Individuals in the Community; The Feeling of Being Open Pilot
2 other identifiers
interventional
9
1 country
1
Brief Summary
The goal of this clinical trial is to pilot an adaptation of mindfulness-based cognitive therapy for chronic pain and early cognitive decline. The main questions it aims to answer in a later fully powered randomized controlled trial are:
- Is an adaptation of mindfulness-based cognitive therapy for older Black adults able to improve quality of life?
- Will an adapted mindfulness based cognitive therapy reduce pain interference to a greater degree than a traditional health enhancement program?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-pain
Started Dec 2024
Shorter than P25 for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 22, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 22, 2025
CompletedFirst Submitted
Initial submission to the registry
September 29, 2025
CompletedFirst Posted
Study publicly available on registry
October 7, 2025
CompletedResults Posted
Study results publicly available
April 17, 2026
CompletedApril 17, 2026
February 1, 2026
8 months
September 29, 2025
January 20, 2026
April 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
The Credibility and Expectancy Questionnaire
The Credibility/Expectancy Questionnaire (CEQ) is a 6-item self-report measure assessing treatment credibility (items 1-3) and expectancy (items 4-6). Items 1-3 and 5 are rated 0 (not at all credible/logical) to 9 (extremely credible/logical), while items 4 and 6 are rated 0% to 100%; subscale scores are standardized and summed (credibility: 3-27 raw equivalent; expectancy similar), with total scores ranging 6-54 after standardization, where higher scores indicate greater credibility and positive outcome expectancy (better outcome).
At enrollment
The Client Satisfaction Questionnaire
The 3-item version of the Client Satisfaction Questionnaire (CSQ-3) is scored by summing responses from its three core items. It consists of empirically selected items measuring key aspects of service satisfaction, each rated on a 4-point Likert scale (1 = lowest satisfaction to 4 = highest, with directionality adjusted as needed). Total scores range from 3 to 12, with higher values indicating greater satisfaction; no reverse scoring or subscales are required.
Administered at the end of treatment at 8 weeks.
Modified Patient Global Impression of Change
The Modified Patient Global Impression of Change (mPGIC) adapts the standard single-item Patient Global Impression of Change (PGIC), a validated patient-reported outcome measure of overall perceived change since intervention, by assessing change across six specific domains. Each domain uses a single ordinal item rated on a 6-point scale: Very Much Improved (coded 5), Much Improved (4), Minimally Improved (3), No Change (2), Minimally Worse (1), or Much Worse (0). The range per domain is 0 (worst, Much Worse) to 5 (best, Very Much Improved), with higher scores indicating greater perceived improvement. Domains are analyzed individually as mean scores (no total computed), where values \>2.5 reflect net positive change. Domains include coping strategies, physical activity, social activity, level of stress, memory and thinking, and pain.
At end of 8 week program (post test) and again at 3 month follow up visit.
Secondary Outcomes (13)
Numerical Rating Scale
From enrollment to 3 months from the end of treatment at 8 weeks.
PROMIS Physical Function
From enrollment to 3 months from the end of treatment at 8 weeks.
PROMIS Anxiety
From enrollment to 3 months from the end of treatment at 8 weeks
PROMIS Emotional Support
From enrollment to 3 months from the end of treatment at 8 weeks
Measure of Current Status Part A
From enrollment to 3 months from the end of treatment at 8 weeks.
- +8 more secondary outcomes
Study Arms (1)
Mindfulness-based cognitive therapy
EXPERIMENTALInterventions
The delivered intervention is mindfulness-based cognitive therapy adapted for the chronic pain and cognitive decline comorbidity among older Black adults. Mindfulness-based cognitive therapy (MBCT) is a structured psychotherapy that integrates mindfulness practices with cognitive behavioral therapy techniques. This adapted MBCT is delivered as an 8-week group-based program with each weekly session lasting about 1 hour. Sessions occur once per week, supplemented by daily home practice of 40-60 minutes, 6 days a week, involving guided meditations, body scans, and mindful activities to reinforce skills.
Eligibility Criteria
You may qualify if:
- Older adult (age ≥ 50)
- All individuals who identify with one or more nationalities or ethnic groups originating in any of the Black racial groups of Africa
- Pain in muscles, joints, bones, or associated soft tissues (NRS\>4) lasting longer than 3 months
- Early Cognitive Decline (subjective or MCI)
- Telephone Interview for Cognitive Status-41 score ≥ 26
- Functional Activities Questionnaire score \< 9
- English fluency/literacy
- Ability and willingness to participate via in-person and video
- Willing to provide informed consent and comply with all aspects of the protocol
You may not qualify if:
- Current substance abuse/dependence
- Significant cognitive impairment
- History of more than 8 sessions of cognitive-behavioral therapy
- History of previous training in mindfulness or undergoing counseling more than once a month
- History of or current diagnosis of psychosis
- Active suicidal ideation or self-harm within the past 90 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Tony V Pham
- Organization
- Massachusetts General Hospital/Harvard Medical School
Study Officials
- PRINCIPAL INVESTIGATOR
Tony V Pham
MGH
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator and Psychiatrist
Study Record Dates
First Submitted
September 29, 2025
First Posted
October 7, 2025
Study Start
December 5, 2024
Primary Completion
July 22, 2025
Study Completion
July 22, 2025
Last Updated
April 17, 2026
Results First Posted
April 17, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
All IPD collected throughout the trial.